BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that it will be presenting at the 20th Annual Symposium on Advanced Wound Care in Tampa, Florida on Monday, April 30th at the 10:30 a.m. session. The title of the presentation is “Thymosin Beta 4 Potential in the Treatment of Dermal Wounds” and will be given by David Crockford, RegeneRx’s vice president of clinical and regulatory affairs.
